MarketFrame

FTSE 100 news / Companies and sectors / AstraZeneca / AstraZeneca opens $1bn Cambridge, Massachusetts R&D centre

AstraZeneca opens $1bn Cambridge, Massachusetts R&D centre

+7.0 strongly positive

Outlets report AstraZeneca opening a Kendall Square R&D centre with over $1bn investment and hiring plans.

38 headlines from 35 outlets, from 6 October 2026 to 8 October 2026. The story's tone is the average of its headlines' own scores.

How each outlet covered it

Average tone of each outlet's headlines in this story. One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.

OutletHeadlinesTone
MarketScreener3+7.1
STAT2+5.0
FirstWord Pharma1+9.2
Contract Pharma1+8.3
The Pharma Letter1+8.3
Oncodaily1+8.3
Connect CRE1+8.3
lifesciencesweden.se1+8.3
Indian Pharma Post1+8.3
pharmaphorum1+7.5
Endpoints News1+7.5
Boston.com1+7.5
Nacionale News1+7.5
Reuters1+7.5
bizjournals.com1+7.5
klsescreener.com1+7.5
AstraZeneca1+7.2
qz.com1+7.2
Yahoo Finance Singapore1+7.2
Breakingthenews.net1+7.2
Investing.com South Africa1+7.2
Investing.com1+7.2
Hoodline1+7.2
Boston Real Estate Times1+7.0
streetinsider.com1+7.0
itemonline.com1+7.0
Securities.io1+7.0
BioSpectrum Asia1+6.7
Yahoo Finance1+6.7
AD HOC NEWS1+6.7
The Boston Globe1+6.3
Healthcare Digital1+5.8
The Business Journals1+5.0
Massachusetts Biotechnology Council1+5.0
hok.com1+4.2

Day by day

Thursday 8 October 2026 5 headlines

Outlets cover AstraZeneca's opening of its $1bn R&D centre in Kendall Square.

Wednesday 7 October 2026 14 headlines

Outlets report AstraZeneca opened a $1bn R&D hub in Kendall Square, Massachusetts.

Tuesday 6 October 2026 19 headlines

Outlets report AstraZeneca opening a Kendall Square R&D centre with over $1bn investment and hiring plans.

AstraZeneca: all news analysis · Sector · FTSE 100 news